- Investopedia•1 hour ago
Industry leaders J&J and Merck & Co. hope to bring transparency to supply-chain dynamics.
- Forbes•2 hours ago
President Donald Trump made a dramatic appeal for lowering the hurdles new medicines face in gaining approval from the Food and Drug Administration. But his promises – that reduced regulatory standards would result in more cures reaching the market and lower drug prices – may be hard to keep.
- Market Realist•4 hours ago
Gilead's liver disease drugs portfolio includes drugs like Sovaldi, Viread, Harvoni, Hepsera, and Epclusa.
MRK : Summary for Merck & Company, Inc. Common St - Yahoo Finance
Merck & Co., Inc. (MRK)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Day's Range||65.90 - 66.79|
|52 Week Range||51.15 - 66.79|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||32.55|
|Dividend & Yield||1.88 (2.85%)|
|1y Target Est||N/A|